SIREN : 810912204
NORCAP is a French company founded 11 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in ROUBAIX (59100), this company of category ETI shows in 2018 a revenue of 2.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicador | 2024 | 2023 | 2022 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Ingresos | N/C | N/C | N/C | N/C | 2 278 873 € | N/C | 366 383 € |
| Resultado neto | 215 508 € | -298 733 € | -20 072 € | 4 505 € | -148 128 € | -194 341 € | -434 487 € |
| EBITDA | N/C | N/C | N/C | N/C | -160 843 € | N/C | -412 962 € |
| Margen neto | N/C | N/C | N/C | N/C | -6.5% | N/C | -118.6% |
In 2024, NORCAP generates positive net income of 216 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
215 508 €
The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 18%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
23.107%
18.131%
19.7%
In 2024, the debt ratio of NORCAP (23.11) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of NORCAP (18.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
The liquidity ratio (= Current assets / Current liabilities) stands at 113.86. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
113.862
In 2024, the liquidity ratio of NORCAP (113.86) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 124 transactions of similar company sales (all years), the value of NORCAP is estimated at 177 043 € (range 67 383€ - 646 539€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare NORCAP with other companies in the same sector:
The revenue of NORCAP in 2018 is 2.3 M€.
Yes, NORCAP generated a net profit of 216 k€ in 2024.
The headquarters of NORCAP is located in ROUBAIX (59100), in the department Nord.
The tax return of NORCAP is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
NORCAP operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.